Trupanion, Inc. (TRUP) Stock
Key stats
- Market cap
- $1.49B
- Price / Earnings ratio
- 55.7x
- EPS (TTM)
- $0.61
- Volume
- Loading
- 52-week high
- $39.97
- 52-week low
- $21.16
Source: third-party data provider, as of November 13, 2026
Compare with TRUP
Recent news

Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
TRUP

Why Trupanion (TRUP) is Poised to Beat Earnings Estimates Again
Why Trupanion (TRUP) is Poised to Beat Earnings Estimates Again
TRUP

TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
TRUP

4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
TRUP
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.17
- MACD 12/26/9
- 2.22
- EMA 9 of MACD
- 1.83
- MACD histogram
- 0.39
- SMA 50
- $27.49
- Price above SMA 50
- EMA 50
- $28.99
- Price above EMA 50
- SMA 200
- $26.66
- Price above SMA 200
- EMA 200
- $28.45
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?
TRUP

Why Trupanion (TRUP) is Poised to Beat Earnings Estimates Again
Why Trupanion (TRUP) is Poised to Beat Earnings Estimates Again
TRUP

TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
TRUP

4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
TRUP

Should You Buy, Sell or Hold Trupanion Stock Post Q2 Earnings?
Should You Buy, Sell or Hold Trupanion Stock Post Q2 Earnings?
TRUP

Trupanion Q2 Earnings Call Highlights
Trupanion Q2 Earnings Call Highlights
TRUP

Compared to Estimates, Trupanion (TRUP) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Trupanion (TRUP) Q2 Earnings: A Look at Key Metrics
TRUP

Trupanion (TRUP) Q2 Earnings and Revenues Beat Estimates
Trupanion (TRUP) Q2 Earnings and Revenues Beat Estimates
TRUP

Why Fast-paced Mover Trupanion (TRUP) Is a Great Choice for Value Investors
Why Fast-paced Mover Trupanion (TRUP) Is a Great Choice for Value Investors
TRUP

Wall Street Analysts Think Trupanion (TRUP) Could Surge 46.25%: Read This Before Placing a Bet
Wall Street Analysts Think Trupanion (TRUP) Could Surge 46.25%: Read This Before Placing a Bet
TRUP
News tone: automated (AI) classification of the article's content, not a price prediction.
About Trupanion, Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Margaret Rosemary Maria Tooth | President, CEO & Director | 1979 |
| Mr. Darryl Graham Andrew Rawlings | Founder & Chair of the Board | 1969 |
| Mr. Fawwad Qureshi | Chief Financial Officer | 1974 |
| Mr. John Gallagher | Chief Operating Officer | 1987 |
| Dr. Steve Weinrauch BVMS, MRCVS | Chief Veterinary & Product Officer | 1975 |
| Ms. Jamie C. Adams | Chief Information Officer | — |
| Ms. Brenna McGibney | Chief Administrative Officer | 1969 |
| Gil Melchior | Director of Investor Relations | — |
| Mr. Asher Benjamin Bearman J.D. | Chief Legal Officer | 1978 |
| Ms. Laura Bainbridge | Senior Vice President of Corporate Communications | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.17
- MACD 12/26/9
- 2.22
- EMA 9 of MACD
- 1.83
- MACD histogram
- 0.39
- SMA 50
- $27.49
- Price above SMA 50
- EMA 50
- $28.99
- Price above EMA 50
- SMA 200
- $26.66
- Price above SMA 200
- EMA 200
- $28.45
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $32.00
- Average
- $33.00
- High
- $34.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -5.1 | +17.7 | ||||||||||
| 2022 | -26.3 | -6.8 | +1.0 | -29.9 | -2.2 | -7.6 | +3.3 | +9.7 | -11.4 | -14.8 | +7.2 | -9.2 |
| 2023 | +29.4 | -2.9 | -25.9 | -17.2 | -39.5 | -12.6 | +47.7 | +1.5 | -4.1 | -26.0 | +25.7 | +3.9 |
| 2024 | -11.6 | -2.4 | +1.2 | -17.9 | +28.1 | +4.6 | +9.2 | |||||
| 2026 | -19.8 | -4.1 | -5.7 | -10.3 | +11.3 | -6.3 | +17.0 | -16.2 | +27.1 | +11.7 |



